113 related articles for article (PubMed ID: 2838970)
41. Transformation of rat 3Y1 cells by a deletion DNA of human papillomavirus type 16 molecularly cloned from genomic DNA of a cervical carcinoma.
Watanabe S; Yoshiike K
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1431-5. PubMed ID: 2838580
[TBL] [Abstract][Full Text] [Related]
42. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein.
Subramanian T; La Regina M; Chinnadurai G
Oncogene; 1989 Apr; 4(4):415-20. PubMed ID: 2524023
[TBL] [Abstract][Full Text] [Related]
43. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages.
Banks L; Moreau F; Vousden K; Pim D; Matlashewski G
J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576
[TBL] [Abstract][Full Text] [Related]
44. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
Thomas M; Matlashewski G; Pim D; Banks L
Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
[TBL] [Abstract][Full Text] [Related]
45. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras.
Rhim JS; Webber MM; Bello D; Lee MS; Arnstein P; Chen LS; Jay G
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11874-8. PubMed ID: 7991549
[TBL] [Abstract][Full Text] [Related]
46. The products of the E5, E6, or E7 open reading frames of RhPV 1 can individually transform NIH 3T3 cells or in cotransfections with activated ras can transform primary rodent epithelial cells.
Ostrow RS; Liu Z; Schneider JF; McGlennen RC; Forslund K; Faras AJ
Virology; 1993 Oct; 196(2):861-7. PubMed ID: 8396814
[TBL] [Abstract][Full Text] [Related]
47. Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells.
Crook T; Storey A; Almond N; Osborn K; Crawford L
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8820-4. PubMed ID: 2848240
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
Massimi P; Pim D; Banks L
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
[TBL] [Abstract][Full Text] [Related]
49. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA.
Stöppler MC; Straight SW; Tsao G; Schlegel R; McCance DJ
Virology; 1996 Sep; 223(1):251-4. PubMed ID: 8806560
[TBL] [Abstract][Full Text] [Related]
50. Transformation assays for HPV oncoproteins.
Massimi P; Banks L
Methods Mol Med; 2005; 119():381-95. PubMed ID: 16350412
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells.
Kanda T; Furuno A; Yoshiike K
J Virol; 1988 Feb; 62(2):610-3. PubMed ID: 2826818
[TBL] [Abstract][Full Text] [Related]
52. Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells.
Garbe J; Wong M; Wigington D; Yaswen P; Stampfer MR
Oncogene; 1999 Apr; 18(13):2169-80. PubMed ID: 10327063
[TBL] [Abstract][Full Text] [Related]
53. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.
Lee CJ; Suh EJ; Kang HT; Im JS; Um SJ; Park JS; Hwang ES
Exp Cell Res; 2002 Jul; 277(2):173-82. PubMed ID: 12083799
[TBL] [Abstract][Full Text] [Related]
54. Determination of the functional difference between human papillomavirus type 6 and 16 E7 proteins by their 30 N-terminal amino acid residues.
Takami Y; Sasagawa T; Sudiro TM; Yutsudo M; Hakura A
Virology; 1992 Feb; 186(2):489-95. PubMed ID: 1310180
[TBL] [Abstract][Full Text] [Related]
55. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
[TBL] [Abstract][Full Text] [Related]
56. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
57. Progression of rat embryo fibroblast cells immortalized with transforming genes of human papillomavirus type 16.
Inoue H; Kondoh G; Kamakura CR; Yutsudo M; Hakura A
Virology; 1991 Jan; 180(1):191-8. PubMed ID: 1845822
[TBL] [Abstract][Full Text] [Related]
58. Conditional immortalization of primary cells by human papillomavirus type 18 E6 and EJ-ras defines an E6 activity in G0/G1 phase which can be substituted for mutations in p53.
Storey A; Massimi P; Dawson K; Banks L
Oncogene; 1995 Aug; 11(4):653-61. PubMed ID: 7651728
[TBL] [Abstract][Full Text] [Related]
59. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
60. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras.
Bristow RG; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Oncogene; 1994 Jun; 9(6):1527-36. PubMed ID: 8183546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
